510(k) K852494
K852494 is an FDA 510(k) premarket notification submitted by Hillcrest Biologicals for the device "CMV-IHA". The FDA issued a decision of Substantially Equivalent on September 16, 1985. The device falls under product code LJO (Antigen, Iha, Cytomegalovirus), a Class II device regulated under 21 CFR 866.3175. Hillcrest Biologicals has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- September 16, 1985
- Date Received
- June 12, 1985
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Antigen, Iha, Cytomegalovirus
- Device Class
- Class II
- Regulation Number
- 866.3175
- Review Panel
- MI
- Submission Type